Testing fluid biomarkers from a chest drain in pleural effusion
Part of Cancer, Lungs & breathing clinical trials.
This trial studies specific markers (biomarkers) found in fluid from a chest drain to better understand pleural effusions (fluid around the lungs), especially when fluid keeps coming back after treatment. You may be helped by contributing to research that could improve how these effusions are diagnosed and managed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can sign consent.
- You have fluid around the lung (pleural effusion) that is due to cancer or is strongly linked to known cancer, with no other clear cause.
- Your symptoms (like shortness of breath, cough, or chest discomfort) improved after draining the fluid with a thoracentesis.
- The fluid returns again after that thoracentesis.
- Your health situation is not too severe—your expected survival is at least 30 days.
- You can safely manage the pleural catheter drainage at home and do the required drain care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects fluid that builds up around your lungs (pleural effusion) during a drainage procedure you already need. Researchers test how different drugs affect your cancer cells in the lab to help predict which treatments might work best for you.
This trial looks at how a breathing control system (called neural respiratory drive) changes when doctors remove lung lining fluid using a thoracocentesis, chest drain, or an indwelling pleural catheter. It may help improve how safe breathing measurements are taken during these common procedures.
This study is looking at certain substances in the fluid around the lungs (pleural effusion) of people with lung adenocarcinoma. It may help doctors understand this condition better and find new ways to treat it.
This study compares several substances found in the fluid around the lungs (pleural effusion) to see whether the fluid is caused by cancer or by non-cancer conditions. It may help doctors figure out the cause faster using pleural fluid test results.
This trial tests a new drug given directly into the chest cavity to treat fluid buildup caused by non-small cell lung cancer. It may help ease breathing problems and control the fluid.
This trial tests a better way to drain fluid from around the lung while you are in the emergency department. It can help you breathe easier and find out what is causing the fluid buildup.
Hear when a new Malignant Pleural Effusions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.